Related references
Note: Only part of the references are listed.Urine N-terminal pro-B-type natriuretic peptide and plasma proenkephalin are promising biomarkers for early diagnosis of cardiorenal syndrome type 1 in acute decompensated heart failure: a prospective, double-center, observational study in real-world
Hong-Liang Zhao et al.
RENAL FAILURE (2022)
Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure
Henrike Arfsten et al.
ESC HEART FAILURE (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Epidemiology of heart failure
Amy Groenewegen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury
Mina Khorashadi et al.
NEPHRON (2020)
Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
Prathap Kanagala et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure
Johanna E. Emmens et al.
CIRCULATION-HEART FAILURE (2019)
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
John Molvin et al.
OPEN HEART (2019)
Analytical performance of an immunoassay to measure proenkephalin
Leslie J. Donato et al.
CLINICAL BIOCHEMISTRY (2018)
Proenkephalin in Heart Failure
Daniel Chu Siong Chan et al.
HEART FAILURE CLINICS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
G. Michael Felker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure
Yuya Matsue et al.
JOURNAL OF CARDIAC FAILURE (2017)
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure A GREAT Network Study
Leong L. Ng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure
Boris Arbit et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation
Jozine M. ter Maaten et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Proenkephalin and Prognosis After Acute Myocardial Infarction
Leong L. Ng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Cardiorenal syndrome-current understanding and future perspectives
Branko Braam et al.
NATURE REVIEWS NEPHROLOGY (2014)
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
Raul Herzog et al.
BMC PUBLIC HEALTH (2013)
Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION-HEART FAILURE (2013)
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
Speranza Rubattu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38-and ERK-MAP kinases and NF-κB
J Rosenberger et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
